We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Updates and Technical Support Sample Clauses

Updates and Technical Support. The license to the Licensed Product granted pursuant to Section 2.1 above includes access to any and all Updates (at no additional cost) that are available. Upgrades shall be made available at prices to be determined by agreement of the Parties. Upon Delivery or payment for such Update(s) or Upgrade(s), if any, such Update(s) or Upgrade(s) shall be deemed "Licensed Product". The Sublicensor shall promptly notify the Sublicensee of any and all available Updates and Upgrades developed by or on behalf of the Licensor and made available to the Sublicensor. An Update or Upgrade shall be deemed available when the Licensed Product incorporating such Update or Upgrade is in general commercial use and distribution by Licensor, and not merely in beta testing. Sublicensee shall implement all Upgrades, Deliverables delivered pursuant to a Statement of Work and Updates within thirty (30)
Updates and Technical Support. 6.1. During the term of this Agreement and provided all fees due hereunder have been paid, mindSCOPE shall provide to Customer periodic updates. Customer agrees not to transfer, sell or assign any prior version of the Products or superseded data to any third party. mindSCOPE may from time to time offer new versions of or additional modules to the Products. mindSCOPE reserves the right to discontinue support of non-current versions of the software upon notice to Customer. During the term and subject to the payment of the fees due hereunder, mindSCOPE shall provide technical support for the software in the form of telephonic or email support. 6.2. Customer authorizes mindSCOPE to gather information either electronically or from Customer’s employees pertaining to end user hardware and software configuration for the purpose of determining installation requirements and providing support. 6.3. Customer acknowledges that charges for software upgrades and technical support are included in the subscription. Under no circumstances does mindSCOPE warrant that Products will continue to function without ongoing periodic maintenance. mindSCOPE may from time to time offer new versions of mindSCOPE. Such new versions will be offered to Customer as a part of this License Agreement. mindSCOPE reserves the right to discontinue support in the event Customer fails to: provide payment, receive adequate training, or comply with current hardware, software or system requirements as determined by mindSCOPE.
Updates and Technical Support. Some updates may be technically or legally necessary and the acquirer acknowledges that if the Software is not updated, it may become partially or totally inoperative, or its functionality will not meet the legislative or technical requirements for its use. Software updates are provided solely via the Internet and may alter, modify, add, or remove or disable certain features of the Software or the Software as a whole. The author does not guarantee the technical or user support of the Software.
Updates and Technical Support. 6.1 During the Term of this Agreement, and provided all fees due hereunder have been paid, Xxxxxx shall provide to Customer, periodic database and/or software updates (the “Updates”), as and when published. At Arslan’s request, Customer shall immediately return all superseded Product to Xxxxxx. Customer agrees not to transfer, sell, or assign any prior version of the Product or any superseded data to any third party. Updates are not guaranteed to be published every month, and Customer’s payment(s) shall be due regardless of whether an Update is released in any given month. Arslan may from time- to-time offer new versions of or additional modules to the Product. Such new version or additional modules will be offered to Customer at Arslan’s then current list price and may be licensed at the option of the Customer. Xxxxxx reserves the right to discontinue support of non-current versions of the Software upon notice to Customer. During the term of this Agreement and subject to the payment of the fees due hereunder, Xxxxxx shall provide technical support for the Software in the form of toll-free telephonic support. Information regarding support hours shall be as set forth, from time to time, at the AccuVision- 0X.xxx 6.2 Customer acknowledges that Xxxxxx has licensed the Product from Xxxxxxxx International, Inc. (“Xxxxxxxx”) and that Xxxxxxxx may elect to end-of-life the Product at any point during the term. In such case, Arslan will provide, at no additional charge to Customer, the applicable replacement product of substantially equivalent (or increased) functionality provided that same is provided by Xxxxxxxx to Arslan. In the event that the license between Xxxxxx and Xxxxxxxx is terminated for any reason whatsoever, Xxxxxx shall be entitled to terminate its sublicense of the Product to the Customer, in which event the Customer shall have no recourse against Xxxxxx other than to be reimbursed the pro rata amount of any prepaid fees paid by the Customer for the then current term. 6.3 Customer authorizes Xxxxxx to gather information (either electronically, or from Customer’s employees) pertaining to end user hardware and software configuration for the purpose of determining installation requirements and providing support.
Updates and Technical Support. 6.1. During the term of this Agreement, mindSCOPE shall provide to Customer periodic updates. mindSCOPE reserves the right to discontinue support of non-current versions. mindSCOPE shall remotely provide technical support for the Products. Customer acknowledges that charges for software upgrades and technical support are included in the subscription. mindSCOPE reserves the right to discontinue support in the event Customer fails to provide payment, receive adequate training, or adhere to current hardware and software requirements. 6.2. Customer authorizes mindSCOPE to gather information either electronically or from Customer’s employees pertaining to end user hardware and software configuration for the purpose of providing support.
Updates and Technical Support. Haply may, at its discretion, provide updates, upgrades, bug fixes, modifications, enhancements and new releases and versions to the Software (“Updates”) but Haply has no obligation to do so or provide other technical support unless separately agreed in writing between You and Haply. If Haply makes an Update available, this Agreement will govern the Updates unless the Update is accompanied by a separate license in which case the terms of such license will govern.

Related to Updates and Technical Support

  • Technical Support State Street will provide technical support to assist the Fund in using the System and the Data Access Services. The total amount of technical support provided by State Street shall not exceed 10 resource days per year. State Street shall provide such additional technical support as is expressly set forth in the fee schedule in effect from time to time between the parties (the “Fee Schedule”). Technical support, including during installation and testing, is subject to the fees and other terms set forth in the Fee Schedule.

  • Technical Support Services 2.1 The technical support services (the "Services"): Party A agrees to provide to Party B the relevant services requested by Party B, which are specified in Exhibit 1 attached hereto ("Exhibit 1").

  • Updates and Upgrades Contractor grants to the Eligible User a non-exclusive, non-transferable license to use upgrades and updates provided by Contractor during the Contract Period. Upgrades and updates are subject to the terms of this Contract. The Eligible User reserves the right to accept updates and upgrades at its discretion and to determine if such updates comply with the requirements in the Contract scope of work.

  • Technical Documentation Prior to commencement of the Tests on Completion, the Contractor shall supply to the Engineer the technical documentation as specified in the Employer’s Requirements. The Works or Section shall not be considered to be completed for the purposes of taking- over under sub-clause 10.1 [Taking Over of the Works and Sections] until the Engineer has received the technical documentation as defined in this sub-clause 5.7, the "history file" including design calculations and certain certification as well as any other documents required to meet the CE Marking requirements.

  • Manufacturing Technology Transfer Except as the Committee ------------ --------------------------------- may otherwise agree in writing, in order to effectuate an orderly transition of the uninterrupted availability of Product to LILLY for purposes contemplated under this Agreement, MEGABIOS, at least ninety (90) days prior to completion of the Project or completion of Phase I Clinical Trials, whichever is earlier, shall transfer to LILLY all information and instructions concerning the manufacturing process and related matters in MEGABIOS' possession which may be necessary for LILLY to manufacture Product (including information regarding obtaining necessary Lipids related thereto) for clinical trials and commercialization as contemplated hereunder including, but not limited to, analytical and manufacturing methods. MEGABIOS shall also provide assistance (in the form of consultation) to LILLY with respect to manufacturing matters for a period of [ * ] months after completion of the initial transfer of information and instructions as provided below. Such transfer and assistance by MEGABIOS will be referred to herein as the "Manufacturing Transfer." All such information, methods and instructions transferred to LILLY under this Section 4.3 shall be referred to herein as the "Manufacturing Information," and shall be maintained in confidence by LILLY pursuant to Section 7.1, except that LILLY's obligation to maintain in confidence such Manufacturing Information shall survive for ten (10) years following expiration or termination of this Agreement. LILLY agrees that it will use all such transferred Manufacturing Information only for the manufacture of the Products and shall not disclose or transfer such Manufacturing Information to any third party manufacturer except as provided in Section 2.10. MEGABIOS shall provide, and bear its costs for, up to [ * ] FTEs for a period of up to [ * ] months [ * ] in aggregate) to accomplish the Manufacturing Transfer. Such FTEs, at LILLY's request, shall include visits to LILLY's facilities by MEGABIOS personnel including up to [ * ] from MEGABIOS' head of manufacturing. MEGABIOS shall furnish any additional reasonable assistance beyond the assistance described above regarding manufacturing matters that LILLY may request and that MEGABIOS is able to provide, for up to [ * ] after the initial transfer of Manufacturing Information, providing that LILLY [ * ] incurred with respect to such additional assistance.

  • Research Use Reporting To assure adherence to NIH GDS Policy, the PI agrees to provide annual Progress Updates as part of the annual Project Renewal or Project Close-out processes, prior to the expiration of the one (1) year data access period. The PI who is seeking Renewal or Close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the PI is seeking renewal), any violations of the terms of access described within this Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. The PI also may include general comments regarding suggestions for improving the data access process in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing stewardship of data sharing activities subject to the NIH GDS Policy.

  • Statement of Work The Statement of Work to which Grantee is bound is incorporated into and made a part of this Grant Agreement for all purposes and included as Attachment A.

  • Manufacturing Services Patheon will perform the Manufacturing Services for Products to be distributed and sold by Client in the Territory for the fees specified in Schedules B and C to the relevant Product Agreement. Schedule B to each Product Agreement sets forth a list of cost items that are included in the Price for Products; all cost items that are not included in this list are excluded from the Price and are subject to additional fees to be paid by Client. Patheon may amend the fees set out in Schedules B and C to a Product Agreement as set forth in Article 4. Patheon will perform the Manufacturing Services solely at the Manufacturing Site, unless otherwise agreed in writing by Client. If the parties agree that Patheon will supply, and Client will purchase, at least a specified minimum percentage of Client’s requirements for a Product under a Product Agreement (the “Required Percentage”), then the applicable Product Agreement will set forth the Required Percentage and the time period during which the obligation will apply (the “Required Period”). But this obligation (if any) will cease to apply to Client with respect to the Product if Patheon fails to remain in material compliance with its obligations under this Agreement or the applicable Product Agreement, or Patheon suspends performance under this Agreement or the applicable Product Agreement in connection with a Force Majeure Event or where Patheon is or will be prevented from supplying the Product as a result of the action of a Regulatory Authority. Subject to its obligation (if any) to purchase the Required Percentage of a Product during the Required Period, Client may, at any time, obtain Product from a third party or may, at any time, qualify a third party to perform Manufacturing Services for the Product. In performing the Manufacturing Services, Patheon and Client agree that:

  • Clinical Supply In connection with the Technology Transfer, Lexicon shall transfer to Sanofi any usable inventory of Licensed Compound or Licensed Product, subject to Lexicon’s retention of reasonable requirements of such Licensed Compound or Licensed Product for its T1DM Development activities no later than [**] (or such other date as is agreed by the Parties), and Lexicon’s Manufacturing Cost paid to Lexicon CMOs for such transferred quantities of inventory shall be treated as Development Costs and borne by the Parties in accordance with Section 7.6. Prior to the completion of the Technology Transfer in accordance with Section 6.2, Lexicon shall, to the extent requested by Sanofi and as mutually agreed by the Parties, supply clinical quantities of the Licensed Products and placebo for use by Sanofi in the Development of Licensed Products for T2DM in accordance with the Development Plan, and Lexicon’s Manufacturing Cost incurred in connection therewith shall be treated as Development Costs. After the Technology Transfer, Sanofi shall supply clinical quantities of the Licensed Products and placebo reasonably required by Lexicon for Lexicon’s use in the Development of Licensed Products for T1DM in accordance with the Development Plan and for its own use in the Development of Licensed Products. Lexicon shall Manufacture (or have Manufactured) all such Licensed Product in accordance with Applicable Law and the applicable specifications therefor, including, to the extent required by Applicable Law, cGMP; provided that Lexicon’s liability arising from a breach by the CMO of its agreement with Lexicon shall be limited to such recoveries as are obtained by Lexicon using Commercially Reasonable Efforts to obtain such recoveries and such other remedies as may be available to Lexicon for such breach under its agreement with such CMO. Otherwise, Sanofi’s sole and exclusive remedy and Lexicon’s sole and exclusive liability to Sanofi for any nonconformity shall be for Lexicon to replace such nonconforming Licensed Compound or Licensed Product with conforming Licensed Compound or Licensed Product within reasonable timelines to be mutually agreed by the Parties in writing, but nothing in this Section 6.1.1 shall limit Lexicon’s liability for Third Party Claims under ARTICLE 11. At either Party’s option, Lexicon and Sanofi shall enter into a clinical supply agreement and a reasonable and customary Quality Agreement that shall set forth the terms and conditions upon which Lexicon and any of its Affiliates will conduct their quality activities in connection with such supply, including (i) a right of Sanofi to audit Lexicon and the Lexicon CMOs, (ii) coordination regarding inspections by Regulatory Authorities and (iii) the exchange of information between the Parties regarding the foregoing and quality issues in general. Such agreements shall be negotiated and agreed by the Parties in good faith.

  • PRODUCT MANUFACTURER'S SUPPLIERS Only those dealers/distributors listed by the manufacturer will be considered authorized to act on behalf of the Product Manufacturer.